Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alignment Healthcare, Inc. Director's Dealing 2021

Apr 2, 2021

31270_dirs_2021-04-01_3d76b65a-3fbf-4a56-867e-7f6e089acf78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alignment Healthcare, Inc. (ALHC)
CIK: 0001832466
Period of Report: 2021-03-25

Reporting Person: KOSECOFF JACQUELINE B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-25 Common Stock, par value $0.001 per share ("Common Stock") A 17127 $0.00 Acquired 17127 Direct
2021-03-25 Common Stock A 33333 $0.00 Acquired 50460 Direct
2021-03-30 Common Stock A 10000 $18.00 Acquired 60640 Direct

Footnotes

F1: Represents 11,418 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 5,709 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Kosecoff's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule of the pre-IPO service-based stock appreciation rights. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3.

F2: Represents 33,333 shares of restricted Common Stock of the Company that will vest in equal annual installments on each of the first three anniversaries of the IPO unless Ms. Kosecoff is removed for cause or resigns prior to such dates. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3.

F3: Represents 10,000 shares of Common Stock purchased through a directed share program at the initial offering price of the Common Stock.